Canada’s senior population is growing fast. According to Statistics Canada, by 2031 nearly one in four Canadians will be 65 or older. As we age, staying healthy becomes more challenging—especially during flu season.
For older adults and immunocompromised individuals, the flu isn’t just a seasonal illness. It can lead to serious complications, hospitalizations or even death. That’s why access to high-dose flu vaccines, which offer stronger protection, is so important.
What is a high-dose flu vaccine?
High-dose flu vaccines are designed specifically for older adults. They contain four times more antigen—the ingredient that helps your body build immunity—than regular flu shots. This stronger dose leads to a better immune response.
Studies show that high-dose flu vaccines can:
- Provide 24% better protection than the standard flu vaccine in adults 65 and older.
- Reduce flu-related hospitalizations.
- Lower the risk of pneumonia and other complications.
- Help prevent flu-related deaths in seniors.
The problem: Unequal access across Canada
Despite their effectiveness, many seniors in Canada can’t access high-dose flu vaccines. Here’s why:
Cost
In many provinces, high-dose flu vaccines aren’t covered by public health plans. That means seniors often have to pay out of pocket. For those living on fixed incomes or without private insurance, this cost can be a major barrier.
Regional gaps
Public funding and availability of high-dose influenza vaccines vary by province. For instance, in Alberta, the high-dose vaccine is publicly funded for specific high-risk groups but not for all seniors.
This inconsistent approach means access to a life-saving vaccine can depend entirely on your postal code.
Rural and remote access
Even when the vaccine is covered, it’s not always available. Seniors in rural and remote communities may have to travel long distances to access a pharmacy or clinic that carries it. Public awareness is also often lower in these regions, meaning some people may not know the high-dose vaccine exists.
What needs to change
There are clear, actionable solutions to improve access:
- National public coverage for high-dose flu vaccines would ensure all seniors can receive it, regardless of where they live.
- Improved distribution and outreach—including mobile clinics and better supply for rural pharmacies—would help close regional and access gaps.
- Public education campaign can increase awareness about vaccine options and encourage informed choices.
Why it matters for immunocompromised communities
Seniors and immunocompromised people often face similar risks when it comes to respiratory infections, like the flu. Ensuring access to stronger vaccines is an essential step toward health equity and better protection for all high-risk populations.
Visit Praxus Health, for information and resources about the high-dose flu vaccine.
Take action.
If you or someone you know is interested in joining the Canadian Immunocompromised Advocacy Network, we would love to hear from you.